These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7280130)

  • 1. The prolactin response in patients receiving neuroleptic therapy. The effect of fluphenazine decanoate.
    Dotti A; Lostia O; Rubino IA; Bersant G; Carilli L; Zorreta D
    Prog Neuropsychopharmacol; 1981; 5(1):69-77. PubMed ID: 7280130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circadian behavior of plasma testosterone and gonadotropins during hyperprolactinemia induced by administration of fluphenazine decanoate].
    Magnatta R; Spallone L; Camagna A; Reda G; Bersani G; Dotti A; Lauro R
    Clin Ter; 1980 Mar; 92(5):469-75. PubMed ID: 7449324
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.
    Norman TR; Marriott PF; Kimber NM; Burrows GD
    Int Clin Psychopharmacol; 1987 Oct; 2(4):299-305. PubMed ID: 3693869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
    Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of endogenous hyperprolactinemia induced with administration of fluphenazine decanoate on urinary excretion of sodium and potassium].
    Spallone L; Camagna A; Magnatta R; Reda G; Dotti A; Lauro R
    Clin Ter; 1980 Feb; 92(4):389-97. PubMed ID: 7449318
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA; Silver MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
    Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D
    Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].
    Woggon B; Dick P; Fleischhauer HJ; Gmür M; Gruber G; Angst J; Heimann H
    Int Pharmacopsychiatry; 1977; 12(4):193-209. PubMed ID: 22515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The plasma prolactin level under fluphenazine treatment (author's transl)].
    Hinterhuber H; Platz T; Schwarz S
    Wien Med Wochenschr; 1980 Sep; 130(17):566-70. PubMed ID: 7456470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of fluphenazine and prolactin in psychiatric patients.
    Kitamura T; McGovern DA; Imlah NW; Wiles D; Schiff AA
    Eur Arch Psychiatry Neurol Sci; 1988 Sep; 237(6):320-6. PubMed ID: 3181218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J; Villiger J; Hunter L
    Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
    Goode DJ; Meltzer HY; Fang VS
    Biol Psychiatry; 1981 Jul; 16(7):653-62. PubMed ID: 7196775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
    Iqbal MJ; Young MA; Charles J; Elgart B; Von Greiff H; Simpson GM
    J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study.
    Dudley J; Rauw G; Hawes EM; Keegan DL; Midha KK
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):791-5. PubMed ID: 6686710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fluphenazine on basal prolactin concentrations.
    Chalmers RJ; Bennie EH
    Psychol Med; 1978 Aug; 8(3):483-6. PubMed ID: 704714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.